Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Directorate Change

14 Dec 2018 07:00

RNS Number : 4593K
Ebiquity PLC
14 December 2018
 

 

 Ebiquity plc

("Ebiquity" or "the Company")

 

Directorate Change

 

Ebiquity, a leading independent global media and marketing consultancy, is pleased to announce the appointment of Alan Newman as Chief Financial and Operating Officer. Alan will join the Company on 7th January 2019 and be appointed as an executive Director of the Board. Kevin McNair, currently Interim Chief Financial Officer, will step down from the role and the Board on 7th January 2019.

 

Alan has extensive public company experience having spent almost ten years as CFO of YouGov plc, the AIM-listed global market research and data analytics group. He is currently Chair of the Audit Committee of Future plc and Deputy Chair of the Quoted Companies Alliance. Prior to YouGov plc, Alan was a partner at EY and previously at KPMG where he provided board level advisory and consulting services specialising in the media, technology and telecoms sector. He is a Fellow of the Institute of Chartered Accountants in England and Wales.

 

Michael Karg, Group CEO, Ebiquity says: 

 

"Alan is an exceptional addition to Ebiquity's executive team. He brings a vital combination of public company and media sector expertise as we continue our business transformation. I and the team look forward to working closely with him."

 

Alan Newman says:

 

"Ebiquity is well positioned to take advantage of media industry trends and I feel this is an exciting time to join the business. I look forward to being part of an inspiring team and working with Michael and the Executive team to help Ebiquity to develop and successfully exploit its market opportunities."

 

 

Further information on Alan Newman

Mr Newman (full name Alan Philip Stephen Newman), aged 61 currently holds the following directorships:

Future plc

Freud Museum London (registered charity)

The Quoted Companies Alliance

Freud Museum Publications Limited

Newlawns Limited

 

 

Mr Newman has been a Director of the following companies within the last five years:

YouGov plc

YouGov Services Limited

YGV Finance Limited

YouGovStone Limited

Portent.io Limited

CoEditor Limited

Doughty Media 2 Limited

YouGov America Inc.

YouGov Deutschland GmbH

YouGov France SASU

YouGov Malaysia Sdn, Bhd

YouGov M.E. Egypt LLC

YouGov M.E. FZ-LLC

YouGov Nordic &Baltic A/S

YouGov Research Pty Limited

YouGov Thailand Company Limited

PT YouGov Consulting Indonesia

Consilium Limited, Hong Kong

 

Anyada Limited

 

There is no further information required to be disclosed pursuant to Schedule Two, paragraph (g) of the AIM rules.

14 December 2018

 

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

Mark Sanford (Company Secretary)

Via Instinctif Partners

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

Michael Wharton

 

020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOATJBMTMBIBTAP
Date   Source Headline
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company
19th May 20162:25 pmRNSHolding(s) in Company
11th May 201611:20 amRNSAGM resolutions passed
11th May 20168:50 amRNSExercise of Share Options
29th Apr 20165:30 pmRNSRe Directorate
25th Apr 201610:45 amRNSHolding(s) in Company
15th Apr 20163:40 pmRNSAnnual Report
30th Mar 20167:00 amRNSFinal Results
27th Jan 20167:00 amRNSAppointment of Director and Director Dealing
27th Jan 20167:00 amRNSInterim Results
8th Jan 201611:27 amRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Statement
25th Nov 20152:41 pmRNSDirector Dealing
9th Nov 201512:15 pmRNSCORRECTION - Holding(s) in Company
9th Nov 201510:21 amRNSHolding(s) in Company
6th Nov 201511:53 amRNSHolding(s) in Company
15th Oct 20157:10 amRNSExercise of Share Options
15th Oct 20157:00 amRNSAppointment of director
12th Oct 20152:21 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSDirector Dealings
1st Oct 20157:00 amRNSBoard changes
22nd Sep 20154:48 pmRNSExercise of Share Options
17th Sep 20157:00 amRNSFinal dividend for the year ended 30 April 2015
15th Sep 20153:33 pmRNSResult of AGM
17th Aug 20157:00 amRNSAnnual Financial Report
28th Jul 20157:10 amRNSChange in financial year end
28th Jul 20157:00 amRNSFinal Results
6th Jul 20155:56 pmRNSHolding(s) in Company
25th Jun 201512:15 pmRNSHolding(s) in Company
24th Jun 20154:22 pmRNSHolding(s) in Company
24th Jun 20157:00 amRNSChange to final results announcement date
9th Jun 20154:13 pmRNSHolding(s) in Company
8th Jun 20152:43 pmRNSHolding(s) in Company
8th Jun 201511:10 amRNSHolding(s) in Company
1st Jun 201510:37 amRNSExercise of Share Options
27th May 20157:00 amRNSExercise of Share Options
27th May 20157:00 amRNSPre-close Trading Statement
22nd May 20155:15 pmRNSHolding(s) in Company
19th May 20157:00 amRNSExercise of Share Options
16th Mar 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.